CT Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

CT Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$23.5K	Hold	240	–	–	0.01%	339
2016 Q4	$21.3K	Buy	240 +171	+248%	+$15.6K	0.01%	346
2016 Q3	$6.72K	Sell	69 -93	-57%	-$8.85K	﹤0.01%	475
2016 Q2	$13.9K	Sell	162 -417	-72%	-$37.4K	0.01%	392
2016 Q1	$50.1K	Buy	579 +3	+0.5%	+$268	0.03%	288
2015 Q4	$65K	Hold	576	–	–	0.04%	261
2015 Q3	$58.2K	Hold	576	–	–	0.04%	274
2015 Q2	$70.8K	Hold	576	–	–	0.04%	262
2015 Q1	$65.9K	Buy	576 +3	+0.5%	+$331	0.04%	273
2014 Q4	$58.2K	Buy	+573	New	+$55.7K	0.04%	222
2014 Q1	$65.9K	Buy	+576	New	+$48K	0.04%	273

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CT Financial Advisors's IBB Position: Q1 2017 in Review

CT Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2017 at 240 shares worth $23.5K. The position accounts for 0.01% of the portfolio, ranked #339.

CT Financial Advisors first reported a position in IBB in Q1 2014 and has held it in 11 quarters since. The position peaked at $70.8K in Q2 2015. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

CT Financial Advisors held 240 shares of iShares Biotechnology ETF worth $23.5K as of Q1 2017.
CT Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2017.
iShares Biotechnology ETF made up 0.01% of CT Financial Advisors's portfolio in Q1 2017, its #339 holding.
CT Financial Advisors first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 11 quarters since.
CT Financial Advisors's iShares Biotechnology ETF position peaked at $70.8K in Q2 2015.
520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.